Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change ; volume:143 ; number:4 ; day:23 ; month:2 ; year:2022 ; pages:487-503 ; date:4.2022
Acta neuropathologica ; 143, Heft 4 (23.2.2022), 487-503, 4.2022
- Creator
-
Smirnov, Denis S.
Ashton, Nicholas J.
Blennow, Kaj
Zetterberg, Henrik
Simrén, Joel
Lantero-Rodriguez, Juan
Karikari, Thomas K.
Hiniker, Annie
Rissman, Robert A.
Salmon, David P.
Galasko, Douglas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-022-02408-5
- URN
-
urn:nbn:de:101:1-2022061723243239743063
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smirnov, Denis S.
- Ashton, Nicholas J.
- Blennow, Kaj
- Zetterberg, Henrik
- Simrén, Joel
- Lantero-Rodriguez, Juan
- Karikari, Thomas K.
- Hiniker, Annie
- Rissman, Robert A.
- Salmon, David P.
- Galasko, Douglas
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood-based molecular biomarkers for Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood-based molecular biomarkers for Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Blood-based molecular biomarkers for Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF